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https://doi.org/10.1016/j.celrep.2020.107817SUMMARYProteins of the lipocalin family are known to bind small hydrophobic ligands and are involved in various
physiological processes ranging from lipid transport to oxidative stress responses. The genome of the malaria
parasite Plasmodium falciparum contains a single protein PF3D7_0925900 with a lipocalin signature. Using
crystallography and small-angle X-ray scattering, we show that the protein has a tetrameric structure of typical
lipocalinmonomers; hencewe name itP. falciparum lipocalin (PfLCN).We show thatPfLCN is expressed in the
intraerythrocytic stages of the parasite and localizes to the parasitophorous and food vacuoles. Conditional
knockdown of PfLCN impairs parasite development, which can be rescued by treatment with the radical scav-
enger Trolox or by temporal inhibition of hemoglobin digestion. This suggests a key function ofPfLCN in coun-
teracting oxidative stress-induced cell damage during multiplication of parasites within erythrocytes.INTRODUCTION
Lipocalins are a diverse family of small proteins (typically 160–180
residues)whose functional hallmark is their binding to small hydro-
phobic molecules. Although lipocalins show low overall primary
sequence conservation, they share a similar b-barrel structure
consisting of eight b strands that enclose a hydrophobic binding
pocket and all are part of the larger protein superfamily of calycins
(reviewed inFloweret al., 2000). Theconservationofparticular res-
idues and interactions across the lipocalin protein family supports
a common evolutionary origin, and lipocalins have been identified
and characterized in mammals, insects, plants, and bacteria, with
key roles in specialized biological functions including the transport
of fatty acids, lipids, and hormones, control of cell regulation,
crypticcoloration,enzymatic synthesisofprostaglandins,andpro-
tection fromoxidative stress (Flower, 1996;Ganforninaet al., 2008;
Sanchez et al., 2006; Walker et al., 2006; Charron et al., 2008;
Bishop, 2000). However, lipocalins have not been identified in
archaea, and their identity and function in unicellular eukaryotes,
including important human parasites, remain poorly understood.
The malaria parasite Plasmodium falciparum, which is respon-
sible for more than 400,000 deaths each year (WHO, 2019), is an
intracellular parasite that proliferates within a vacuole in its host
cell. It establishes itself in its vertebrate host by using hepato-This is an open access article under the CC BY-Ncytes for an initial multiplication step before undergoing further
massive replication within erythrocytes, and it is this blood stage
of development that is responsible for all clinical symptoms of
malaria. To fuel the parasite’s rapid growth over its 48-h erythro-
cytic life cycle, the parasite not only feeds on its host cell but also
transforms it, establishing new transport systems that allow
direct access to nutrients from the surrounding bloodstream.
Underpinning the malaria parasite’s rapid growth are highly effi-
cient membrane synthesis and recycling pathways that provide
the structural constituents for cell growth and multiplication.
For instance, the phospholipid content of the erythrocyte in-
creases almost 5-fold during intraerythrocytic development, as
the parasite generates the membranes needed for growth and
division (Tran et al., 2016). Fatty acids, the building blocks of
lipids, are typically scavenged from the host but the presence
of a functional FASII system in the apicoplast (specialized chlo-
roplast-derived organelle) also enables the parasite to synthe-
size fatty acids de novo (reviewed in Tarun et al., 2009). How
these essential building blocks of membranes are transported
from the host and within the parasite is not known.
The rapid growth of the parasite in its host cell not only de-
pends on sufficient nutritional uptake but also on a tightly
controlled redox homeostasis. In erythrocytes, the primary




OPEN ACCESSHb degradation occurs in the acidic environment of the digestive
or food vacuole (FV) and involves the endocytic uptake of host
cell cytosol across both the parasitophorous vacuole membrane
(PVM) and the parasite plasma membrane (PPM) (reviewed in
Wunderlich et al., 2012). A major waste product of Hb digestion
is toxic free heme (ferriprotoporphyrin IX), most of which is
detoxified by biomineralization into the inert crystalline form he-
mozoin. Oxidation of Hb-bound iron during Hb digestion leads to
the release of superoxide radicals. The superoxide anion dismu-
tates into hydrogen peroxide, which together with the free iron of
Hb digestion can lead to the formation of hydroxyl radicals via
the Fenton reaction. These radicals are highly reactive and can
cause membrane damage by lipid peroxidation (Jortzik and
Becker, 2012; Atamna and Ginsburg, 1993). It is thus not surpris-
ing that Plasmodium-infected erythrocytes show much higher
levels of reactive oxygen species (ROS) relative to uninfected
erythrocytes (Atamna and Ginsburg, 1993). Protection against
oxidative damage is therefore of particular importance for
parasite survival, and parasites remain reliant on various detox-
ification pathways including glutathione and thioredoxin redox
systems, members of which have been shown to be essential
for blood stage parasite development (reviewed in M€uller,
2004; Jortzik and Becker, 2012).
In bacterial and eukaryotic cells, members of the lipocalin fam-
ily are key components of lipid transport and can also mediate
control of ROS damage to membranes (Flower, 1996; Ganfor-
nina et al., 2008; Sanchez et al., 2006; Walker et al., 2006; Char-
ron et al., 2008; Bishop, 2000). To date, no lipocalin has been
structurally or functionally characterized in the diverse parasitic
phylum of Apicomplexa, and a potential role for members of
this protein family in survival and virulence of these important hu-
man and livestock pathogens has not been investigated. Here,
we identify and characterize a lipocalin in the human malaria
parasite Plasmodium falciparum (PlasmoDB: PF3D7_0925900)
based on structural analysis and show that it is important for
parasite survival within erythrocytes.
RESULTS
Identification and Evolutionary Analysis of Lipocalin-
Like Proteins in P. falciparum and Related Protists
Database analysis on PlasmoDB (Aurrecoechea et al., 2009) re-
vealed PF3D7_0925900 as the only gene in the genome of
P. falciparum 3D7 containing a calycin and lipocalin superfamily
signature (Mitchell et al., 2019; Pandurangan et al., 2019). The
encoded protein, which we term P. falciparum lipocalin (PfLCN),
is 217 amino acids in length and contains a predicted N-terminal
signal peptide. During the asexual multiplication of the parasite in
erythrocytes, PfLCN shows highest expression during tropho-
zoite development based on RNA sequencing (Otto et al.,
2010). Expression of mRNA is also detected in gametocytes
and ookinetes (López-Barragán et al., 2011). In addition, expres-
sion is visible in oocysts, while expression levels in sporozoites
appear to be rather low (Zanghı̀ et al., 2018). Endogenous
tagging of the PfLCN homolog in the rodent malaria model Plas-
modium berghei also suggests expression in liver stage para-
sites (Matz and Matuschewski, 2018). Sequence comparisons
show that PfLCN is highly conserved between different Plasmo-2 Cell Reports 31, 107817, June 23, 2020dium species with 65% to 99.5% pairwise sequence identities
(Figure S1). In contrast, low pairwise identities of 23% to 27%
were observed for lipocalin-like proteins in Toxoplasma
gondii (GenBank: CEL71535), Neospora caninum (GenBank:
XP_003879719), and Hammondia hammondi (GenBank:
KEP62611), and blastp searches did not yield any significant
sequence alignments to species outside the apicomplexan line-
age, where overall pairwise sequence identities to known lipoca-
lin proteins dropped below 20%, making it difficult to detect
more distant homologous proteins at the sequence level. There-
fore, we relied upon annotations based on libraries of protein
signatures provided by the SUPERFAMILY and other databases
integrated in InterPro to identify additional putative lipocalins
(Mitchell et al., 2019; Pandurangan et al., 2019). Interestingly,
whenwe did a comparative analysis of the genomes of other api-
complexan parasites and their closest free-living non-parasitic
relatives for the presence of proteins belonging to the lipocalin
(SUPERFAMILY: SSF50814) and calycin (InterPro: IPR012674)
homologous superfamily, we found that most parasitic species
encode one to three putative lipocalin-like genes only, while in
most of the free-living relatives a substantially higher number
of putative lipocalin-like genes can be found even when different
genome sizes are taken into account (Figure S2). This may hint to
a potential gene reduction of the lipocalin family during apicom-
plexan evolution as an adaptation to the intracellular parasitic
lifestyle.
X-ray Crystallography of Recombinant PfLCN Reveals a
Typical Lipocalin Structure
Lipocalins have a characteristic structure consisting of eight
anti-parallel b-barrel strands that form a hydrophobic binding
pocket (Flower, 1996). To validate PfLCN as a lipocalin, we re-
combinantly expressed it in E. coli without the signal peptide
(all residue numbering and molecular weights that follow reflect
this) and determined its structure using X-ray crystallography
to a resolution of 2.85 Å (Figures 1A, 1B, and S3). The structure
has been deposited with the PDB (PDB: 6TLB). In this crystal
structure, PfLCN is arranged as a tetramer and the monomers
superimpose with a root-mean-square deviation (RMSD) of
<0.5 Å over all Ca atoms, indicating high similarity (Figure 1A;
Video S1). The tetramer displays a 2-fold symmetry and is
composed of a dimer of dimers. The dimeric interface is very sta-
ble, with a solvation energy of around17 kcal$mol1 calculated
using the PISA server (Krissinel and Henrick, 2007), and this is
strongly driven by hydrophobic effects.
The overall monomeric structure of PfLCN reveals the classic
lipocalin fold with a b-barrel calyx core consisting of eight
hydrogen-bonded anti-parallel b strands and an N-terminal a he-
lix (a3) perpendicular to the lumen of the barrel (Figure 1B; Video
S2). There is a typical lipocalin binding pocket with a highly
hydrophobic environment inside the b barrel where non-polar li-
gands usually bind in most lipocalins, for example the many lipo-
philic ligands of the human lipocalin NGAL (Bao et al., 2015). The
binding pocket of PfLCN can be measured as approximately
20 Å by 20 Å at the widest span, which is in a similar range to
other lipocalins (Campanacci et al., 2004; Eichinger et al.,
2007). The bottom of the barrel is closed by the inter-strand
hydrogen bonds between b strands 3 and 6, and also a 310 helix.
Figure 1. PfLCN Forms a Tetrameric Structure of Typical Lipocalin Monomers
(A) Crystal structure of tetrameric PfLCN.
(B) Crystal structure of monomeric PfLCN. The N and C termini are labeled, as are various structural features including the two disulfide bonds.
(C) Representation of coulombic surface charges on PfLCN. Red indicates net positive-charge regions; blue indicates net negative-charge regions. The left view
shows the top-down view looking into the binding pocket, while the right view displays a bottom-up view. For details regarding data collection statistics and
refinement statistics, see also Figure S3.
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ll
OPEN ACCESSThis is a feature also shared with other lipocalins. The available
protein structure with the highest degree of similarity to PfLCN
is the E. coli lipocalin Blc (Campanacci et al., 2004) with a
RMSD of 1.7 Å, and a modified version of Blc was used as a mo-
lecular replacement model during structure determination. Inter-
estingly, structural comparisons of PfLCN with human lipocalins
(Breustedt et al., 2006) revealed that among thesePfLCN has the
highest structural similarity with the high-density lipoprotein
ApoD (Eichinger et al., 2007) (Figure S4) with a RMSD of 1.8 Å.
The sequence homology of both Blc and ApoD when compared
to PfLCN are nevertheless low, with 16.8% and 19.2% sequence
identity, respectively.
The surface charges of PfLCN are distributed mostly on the
underside of the barrel and are mainly constituted of positively
charged residues. However, both the dimerization face and the
binding face are largely composed of non-polar residues, al-
lowing both a hydrophobic effect-driven dimerization and also
the direction of hydrophobic ligands into the binding pocket,
which contains mostly non-polar residues (Figure 1C). There
are two disulfide bonds located close to each other in each
monomer (Figure 1B). One disulfide bond (C49-C195) anchors
the C-terminal tail to the body of the protein, which is a featurewell conserved among lipocalins (Flower, 1996). However, the
other disulfide bond (C47-C72) is more unusual in the family
and binds the terminus of a2, the helix that appears to be
‘‘gating’’ the entrance to the binding pocket, to b4, one of the
longest strands of the barrel. The binding pocket in the struc-
ture is mostly occluded by the a2 helix, and while this does
not rule out the possibility of ligand binding in these conditions,
the C47-C72 disulfide bond may be contributing to controlling
access to the pocket.
To investigate whether the tetramer observed in the crystal
structure was a physiologically relevant oligomer, we per-
formed small-angle X-ray scattering (SAXS) experiments.
These confirmed the presence of a tetramer in solution, and
that this tetramer exhibits a concentration-dependent equilib-
rium with dimeric PfLCN (Figure 2). The dimer obtained from
SAXS modeling spatially superimposes well with the crystallo-
graphic dimer, which along with the favorable solvation
enthalpy gives an indication that this is a stable, physiological
dimer. In the crystallographic tetramer and the SAXS-derived
dimer, all binding sites are pointing outward, allowing each
monomer to potentially bind to a ligand in this state and
remain functional.Cell Reports 31, 107817, June 23, 2020 3
Figure 2. SAXS Analysis of the Oligomerization of PfLCN in Solution
(A) SAXS raw data were taken over a range of concentrations of PfLCN in batch mode and also include a size-exclusion chromatography SAXS (SEC-SAXS) run.
From bottom to top, the datasets are as follows: a SEC-SAXS run, 1, 2, 5, and 10mg$mL1. The fitted lines represent the calculated scattering from the tetramer-
dimer mixtures given in (D), using the software SASREFMX. The X2 functions of each fit are, respectively, as follows: 0.98, 0.98, 1.0, 1.2, and 1.3. The datasets are
offset by a factor of 10 each time for clarity.
(B) Graph shows concentration of PfLCN plotted against average molecular weight (Mw) of the sample on the left y axis. On the right y axis is the ratio of this Mw
compared to the monomer Mw. The SEC-SAXS sample is not plotted on the graph as it is not possible to work out the protein concentration using this technique.
(C) The average hydrodynamic radius (Rg) plotted against concentration.
(D) The proportion of tetrameric and dimeric PfLCN present at different concentrations, calculated using the software SASREFMX.
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OPEN ACCESSPfLCN Localizes to the PV and FV and Can Integrate into
Membranes
Having shown thatPfLCN is indeed a lipocalin based on its struc-
ture, we next determined its localization by endogenously
tagging PfLCNwith green fluorescent protein (GFP) using the se-
lection-linked integration (SLI) system (Birnbaum et al., 2017).
We additionally introduced a GlmS ribozyme (Prommana et al.,
2013) sequence upstream of the 30 untranslated region that al-
lows inducible knockdown of protein expression upon addition
of glucosamine to the parasite culture medium (Figure 3A). In
parallel, we generated a similar parasite line, in which the GlmS
ribozyme sequence was inactivated (M9 mutant; Prommana
et al., 2013). Correct integration of both of the corresponding tar-
geting constructs into the endogenous PfLCN locus was
confirmed by PCR (Figure 3B). In the following, the resulting
parasite lines are referred to as PfLCN-knockdown (LCN-Kd,
GlmS-WT sequence) and PfLCN-control parasites (LCN-Con,
GlmS-M9 sequence).
Live-cell microscopy of LCN-Kd parasites revealed that in
rings and early trophozoites PfLCN-GFP localized to the parasite
periphery, suggesting a possible localization on the PVM, the
PPM, or within the PV itself (Figure 3C). In trophozoites and early
schizonts, the protein was additionally visible in small, mostly pe-4 Cell Reports 31, 107817, June 23, 2020ripheral, focal structures, in accumulations in the parasite
cytoplasm as well as in the FV. The localization to the FV in tro-
phozoites was further verified using the FV membrane marker
P40PX-mCherry (Jonscher et al., 2019), which was coexpressed
in LCN-Kd parasites (Figures 3D and S5). In schizonts, wemainly
observed the PfLCN signal around developing merozoites, in
some accumulations in the schizont cytoplasm and in the FV.
In contrast, in free merozoites PfLCN was present in the cytosol
but no GFP signal was evident around their periphery, excluding
a localization to the PPM and further supporting that PfLCN lo-
calizes to the PV and possibly on the PVM of the infected eryth-
rocyte (Figure 3C).
Given that several lipocalins, including E. coli Blc and human
ApoD, have the capability to integrate into membranes (Hernán-
dez-Gras and Boronat, 2015; Eichinger et al., 2007; Bishop et al.,
1995), we next investigated the membrane association of PfLCN
and performed sequential differential solubilization of lysed para-
site membranes. To this aim, saponin (permeabilizes erythrocyte
membrane and PVM) pellets of LCN-Kd trophozoite stage
parasites were hypotonically lysed to release non-membrane-
associated proteins and then sequentially treated with sodium
carbonate and Triton X-100 to solubilize peripheral and integral
membrane proteins, respectively. Western blot analysis using
Figure 3. Endogenous Tagging and Localization Analysis of PfLCN
(A) Schematic of the selection-linked integration-based strategy used to generate LCN-Kd and LCN-Con parasites by single-crossover recombination. Local-
ization of primers used for showing successful integration of targeting constructs by PCR are indicated. T2A, skip peptide; Neo-R, neomycin-resistance gene;
GlmS, GlmS ribozyme; asterisks, stop codons; arrows, promoters.
(B) Integration PCR of transgenic LCN-Kd and LCN-Con knockin (KI) and unmodified wild-type (WT) parasites.
(C and D) Localization of PfLCN-GFP (green) by live-cell microscopy. In (C), the localization in ring (R), trophozoite (T), early schizont (ES), and late schizont (LS)
stage parasites as well as in free merozoite (M) is shown. In (D), the FV membrane marker P40PX-mCherry (red) was coexpressed in LCN-Kd parasites. Nuclei
were stained with DAPI (blue). DIC, differential interference contrast. Scale bar, 5 mm. Further images of LCN-Kd trophozoite stage parasites expressing P40PX-
mCherry are shown in Figure S5.
(E) Sequential differential solubility analysis of PfLCN-GFP parasite saponin pellet by hypotonic lysis (soluble proteins), treatment with sodium carbonate
(Na2CO3, peripheral membrane proteins) and Triton X-100 (integral membrane proteins). The soluble protein aldolase and the integral membrane protein
skeleton-binding protein 1 (SBP1) served as positive controls for cytosolic and integral membrane proteins, respectively. To further control for extraction
(legend continued on next page)






OPEN ACCESSanti-GFP antibodies revealed that an approximately 50-kDa
PfLCN-GFP (calculated molecular weight 50.8 kDa) was not
only found in the soluble fraction but also in the sodium carbon-
ate and Triton fraction, indicating that it is a soluble protein but
that it can also associate with and integrate intomembranes (Fig-
ure 3E). Interestingly, we also detected a higher molecular mass
GFP-positive band, which likely represents PfLCN in its dimeric
state as previously described for other lipocalins (Bhatia et al.,
2012; van Veen et al., 2006; Kielkopf et al., 2018) and as also sup-
ported by our SAXS analysis. In addition to these bands, a third
band at around 25 kDa was visible that likely represents cleaved
GFP. This band is often detected in GFP-fusions in P. falciparum,
in particular for PV and FV proteins (Klemba et al., 2004; Boddey
et al., 2016), and was solely found in the soluble fraction, further
underlining the specificity of PfLCN’s membrane association.PfLCN Is Important for Parasite Survival in Erythrocytes
In order to test whether PfLCN is essential for blood stage prolif-
eration, we first tried to functionally inactivate it by targeted-gene
disruption using the SLI system (Birnbaum et al., 2017). Howev-
er, repeated attempts failed to obtain parasites carrying the
correctly integrated plasmid, pointing toward an important func-
tion of PfLCN that is required for parasite growth.
We next aimed to conditionally downregulate PfLCN expres-
sion and to study the influence of this on parasite development.
To test whether the GlmS-system can be used to investigate
PfLCN function, we first added 2.5 mM glucosamine to tightly
synchronized early ring stage LCN-Kd and LCN-Con parasites
and measured PfLCN expression 24 h post glucosamine addi-
tion by quantitative western blot analysis. This revealed a
>95% knockdown of the protein in LCN-Kd parasites upon
glucosamine addition, while no influence on PfLCN expression
was seen in LCN-Con parasites, showing efficient regulation of
PfLCN expression by the GlmS ribozyme (Figure 4A).
To assess the influence of PfLCN knockdown on parasite
multiplication, we next quantitated the growth of LCN-Kd and
LCN-Con parasites with and without glucosamine using a flow
cytometry-based growth assay over four parasite cycles. Addi-
tion of glucosamine to LCN-Kd parasites resulted in a pro-
nounced growth defect, which was already visible in the first
parasite cycle following glucosamine addition (Figure 4B). In
contrast, no noticeable growth defect was evident for LCN-
Con parasites treated with glucosamine, thereby excluding
that the observed growth defect in LCN-Kd parasites is due to
glucosamine cytotoxicity. To further verify that the observed
reduction in multiplication of LCN-Kd parasites grown in the
presence of glucosamine is due to the knockdown of PfLCN,
we complemented LCN-Kd parasites with an episomal plasmid,
from which the PfLCN coding sequence is expressed as a fusion
with mCherry under the constitutive nmd3 promoter (Birnbaum
et al., 2017). As expected, in these parasites, the mCherry-
taggedPfLCN showed a clear PV localization in addition to a pro-efficiency, blots were also probedwith an antibody against erythrocyte spectrin, w
(Thakur et al., 2015; Spillman et al., 2016). The band at around 25 kDa in the so
monomeric PfLCN-GFP, while the higher molecular band at around 90 kDa is likely
independent experiments, of which one is shown.
6 Cell Reports 31, 107817, June 23, 2020nounced staining of the parasite FV (Figure 4C). Importantly,
when we added glucosamine to these complemented parasites,
the growth defect was reversed, confirming that knockdown of
PfLCN is specific and deleterious for parasite growth (Figure 4B).
PfLCN Knockdown Impairs Late Stage Maturation
To determine which particular parasite stage is affected by the
knockdown of PfLCN, we added glucosamine to tightly synchro-
nized LCN-Kd and LCN-Con ring stage parasites and quantified
the different parasite stages at 24, 40, and 48 h post-invasion
(hpi). While we did not see any major effect on trophozoite and
schizont numbers upon PfLCN knockdown, there was a sub-
stantial reduction of newly formed rings at 48 hpi. As expected,
no such effect was seen in LCN-Con parasites after glucosamine
addition (Figures 4D and S6). To investigate this further, we
analyzed schizont morphology in Giemsa-stained blood smears
of untreated and glucosamine-treated LCN-Kd and LCN-Con
parasites that had been incubated with the egress inhibitor com-
pound 2 from 40 to 48 hpi. Interestingly, there was a statistically
significant increase of schizonts with abnormal morphology
upon glucosamine addition to LCN-Kd parasites, suggesting
that PfLCN knockdown affects late stagematuration of the para-
site (Figure 4E).
PfLCN Function Affects Hemozoin Crystal Motility in the
FV and Is Related to the Activity of ROS
To understand the late stage maturation defect of PfLCN knock-
down parasites in more detail, we also studied LCN-Kd and
LCN-Con trophozoite stage parasites by live-cell microscopy.
Interestingly, glucosamine addition to LCN-Kd but not to LCN-
Con parasites nearly completely abolished the motion of hemo-
zoin crystals that under normal circumstances move within the
food vacuole of individual parasites (Figure 5A; Videos S3 and
S4). Hemozoin dynamics serve as internal biomarker for food
vacuole integrity and parasite viability, although the origin and
physiological significance of this motion is unknown so far (Si-
gala and Goldberg, 2014). A loss of hemozoin crystal motility
was previously observed by photoillumination of the heme syn-
thesis intermediate protoporphyrin IX due to the generation of
ROS (Sigala et al., 2015). Based on this, we hypothesized that
the observed loss of hemozoin crystal motility in PfLCN knock-
down parasites is connected to ROS activity. To test this, we
induced the knockdown of PfLCN in LCN-Kd parasites in the
presence of the radical scavenger Trolox, a water-soluble analog
of vitamin E. Remarkably, this resulted in a partial rescue of the
hemozoin crystal motility phenotype, implying ROS mediated
oxidation in the loss of hemozoin motility (Figure 5A). In line
with this, treatment of LCN-Kd parasites with the thiol-reactive
chemical diamide, which has been shown to induce oxidative
stress in the parasite (Rahbari et al., 2017), also inhibited hemo-
zoin crystal motility. Again, this drug-induced motility arrest
could partially be restored by the addition of Trolox (Figure 5B).hich has previously been determined to solubilize in carbonate and Triton X-100
luble fraction likely represents monomeric GFP, the band at around 50 kDa is
derived from dimeric PfLCN-GFP. Solubility results are representative of three
Figure 4. PfLCN Is Important for Parasite Growth and for Late Stage Maturation
(A) Western blot of LCN-Kd and LCN-Con trophozoite stage parasites, which had been treated for 24 h with 2.5 mM glucosamine or which were left untreated.
Aldolase served as a loading control. Quantification of monomeric PfLCN-GFP levels normalized to the amount of aldolase is displayed on the right. Shown are
means ± SD of three independent experiments, in which PfLCN-GFP levels of untreated parasites were always set to 100%. The band at around 25 kDa most
(legend continued on next page)






OPEN ACCESSPfLCN Reduces Oxidative Cell Damage
To further analyze the importance of ROS, we induced the
knockdown of PfLCN in the presence or absence of Trolox.
Concordantly with the rescue of hemozoin crystal motility, Trolox
treatment chemically complemented around 50% of the growth
defect of PfLCN knockdown parasites (Figure 5C), suggesting
that PfLCN function might be associated with protection from
ROS or ROS-induced cell damage. In order to control for the
possibility that Trolox treatment non-specifically protects para-
sites from cell death, we also treated them with the drug
DSM1, which targets dihydroorotate dehydrogenase in the
mitochondrial electron transport chain leading to inhibition of py-
rimidine biosynthesis (Phillips et al., 2008). However, Trolox
treatment failed to restore growth of parasites treated with
DSM1and insteadpotentiated the activity of the drug (Figure 5D).
As another control, we conditionally mislocalized the GTPase
Rab5a since inactivation of this protein causes a similar pheno-
type to PfLCN with a defect in late stage parasite maturation
(Birnbaum et al., 2017). Importantly and in contrast to PfLCN
knockdown, no difference in growth was observed upon Trolox
treatment here (Figure 5E), further highlighting the specificity of
the Trolox-based rescue of parasite growth upon PfLCN
knockdown.
One main source of ROS in infected erythrocytes is the degra-
dation of hemoglobin within the parasite FV (Atamna and Gins-
burg, 1993), and this process can be inhibited by application of
protease inhibitors (Atamna and Ginsburg, 1993; Mesén-Ram-
ı́rez et al., 2019). We therefore tested whether temporal inhibition
of hemoglobin digestion through the addition of the cysteine pro-
tease inhibitor E64 similarly rescues growth of PfLCN knock-
down parasites. To do so, 1 mM E64 was added to ring stage
LCN-Kd parasites in the presence or absence of glucosamine
with E64 beingwashed away after 12 h, a treatment that was pre-
viously shown to be effective in inhibiting hemoglobin digestion
(Mesén-Ramı́rez et al., 2019). Temporal E64 application also
led to a statistically significant rescue of the PfLCN knock-
down-induced growth inhibition (Figure 5F), which combined
with the ability of Trolox to rescue growth of PfLCN knockdown
parasites supports that this protein might have a role in protec-
tion from ROS that is produced during hemoglobin digestion in
the FV.
Protection from ROS could occur through direct lowering of
ROS levels or by mitigating ROS-induced cell damage. To differ-probably represents monomeric GFP, the band at around 50 kDa is monomeric P
from dimeric PfLCN-GFP.
(B) Growth analysis of LCN-Kd, LCN-Con, and complemented LCN-Kd (LCN-Co
glucosamine. Shown are relative parasitemia values, which were obtained by divi
corresponding untreated ones. Shown are means ± SD of four independent grow
Comp parasites in comparison to LCN-Con parasites, a one-way analysis of va
formed. All statistically significant differences are indicated (*p < 0.05; ****p < 0.0
(C) Localization of PfLCN-mCherry in complemented parasites by live-cell mic
contrast. Scale bar, 5 mm.
(D) Stage quantifications of LCN-Kd and LCN-Con parasites grown in the pres
representative of three independent experiments, of which one is shown. The re
(E) Quantification of schizont morphology of compound 2 arrested LCN-Kd and L
Shown are means ± SD of three independent experiments. For statistical evalua
nificant differences are indicated (***p < 0.001; n.s., not significant). Representativ
on the left. Scale bar, 5 mm.
8 Cell Reports 31, 107817, June 23, 2020entiate these possibilities, we measured ROS levels in untreated
and glucosamine-treated LCN-Kd and LCN-Con trophozoite
stage parasites by determining the fluorescence intensity of
the ROS-sensitive dye CellROX Orange (Figure 5G). Interest-
ingly, ROS levels were slightly lower in glucosamine-treated
LCN-Kd parasites in comparison to untreated parasites, while
no such effect was visible in glucosamine-treated LCN-Con par-
asites (Figure 5H). In parallel to measuring ROS levels, parasite
size was also measured in PfLCN knockdown parasites showing
a slight decrease in size (Figure 5I). It is possible that this differ-
ence in size occurs as a result of impaired food vacuole physi-
ology, which may influence CellROX staining intensity as well.
Nevertheless, the fact that PfLCN knockdown did not lead to
an increase in parasite ROS compared to wild-type parasites
during trophozoite development, suggests that it most likely
has a role in reducing oxidative stress-induced cell damage.
DISCUSSION
Lipocalins are a large family of small proteins that play important
roles in various different physiological functions. They are part of
the larger calycin protein superfamily and share a highly
conserved three-dimensional structure but show unusually low
levels of sequence similarity. Due to the extreme sequence di-
versity among lipocalins with pairwise identities falling below
20%, it remains challenging to reliably predict new members of
the lipocalin family in genomes using sequence search methods.
Predictions that rely on a single computational tool may even
miss some of the well-characterized lipocalin family members,
and therefore, they need to be complemented by different
methods. Machine learning approaches have been proposed
(Ramana and Gupta, 2009), but the currently available algo-
rithms proved unreliable in this study and failed to identify the
PfLCN sequence as a lipocalin (Ramana and Gupta, 2009).
Here, using a targeted search informed by libraries of protein
signatures and hidden Markov models that are implemented in
integrated database resources, we identified a member of the
lipocalin protein family in P. falciparum malaria parasites. We
confirmed that PfLCN has a typical lipocalin fold through crystal-
lization and structure solution of the protein.
Remarkably, when the crystal structure of PfLCN was solved,
it was found to be present as a tetramer containing a dimer of di-
mers. Using SAXS analysis, we confirmed that PfLCN also formsfLCN-GFP, while the higher molecular band at around 90 kDa is likely derived
mp) parasites over four parasite cycles in the presence or absence of 2.5 mM
ding the parasitemia of glucosamine-treated cultures by the parasitemia of the
th experiments. For statistical evaluation of the growth of LCN-Kd and LCN-
riance (ANOVA) followed by a Holm-Sidak multiple-comparison test was per-
001).
roscopy. Nuclei were stained with DAPI (blue). DIC, differential interference
ence or absence of 2.5 mM glucosamine at 24, 40, and 48 hpi. Results are
sults of all independent experiments are displayed in Figure S6.
CN-Con schizonts grown in the presence or absence of 2.5 mM glucosamine.
tion, an unpaired two-tailed Student’s t test was performed. Statistically sig-
e Giemsa-stained schizonts with normal and abnormal morphology are shown
Figure 5. PfLCN Protects Parasites against Oxidative-Stress-Induced Cell Damage
(A) Hemozoin crystal motility analysis of LCN-Kd and LCN-Con trophozoite stage parasites grown in the presence or absence of 2.5 mM glucosamine. In a
separate culture, 100 mM of the radical scavenger Trolox was added to LCN-Kd knockdown parasites.
(B) Hemozoin crystal motility analysis of LCN-Kd trophozoite stage parasites to which 10 mMdiamide in presence or absence of 100 mMTrolox was added for 4 h
before analysis. Shown are means ± SD of five independent experiments. For statistical comparisons, a one-way ANOVA followed by a Holm-Sidak multiple-
comparison test was performed. Statistically significant differences are indicated (*p < 0.05; ***p < 0.001; ****p < 0.0001; n.s., not significant). Please see also
Videos S3 and S4.
(C and D) Growth analysis of LCN-Kd parasites over one parasite cycle grown in the presence or absence of 2.5 mM glucosamine (C) or 0.24 mM DSM1 (D) to
which 100 mM Trolox was added or which were left untreated.
(E) Growth analysis over one parasite cycle of Rab5a knocksideways parasites grown in presence or absence of 40 nM Rapalog to which 100 mM Trolox was
added or which were left untreated. Note that the amounts of DSM1 and Rapalog were chosen to mimic approximately the reduction in growth observed upon
PfLCN knockdown.
(legend continued on next page)






OPEN ACCESSa tetramer in solution and is in a concentration-dependent equi-
librium with its dimeric form. This observation excludes that tet-
ramerization is an artifact of the crystallization process. Oligo-
merization is a common feature of lipocalins and often occurs
upon ligand binding (Kielkopf et al., 2018). The fact that PfLCN
was in an oligomeric state in the crystal structure and in solution
without a ligand bound suggests that the multimerization of
PfLCN occurs independently of its ligand. Interestingly, a higher
molecular mass GFP-positive band was also observed in addi-
tion to the one corresponding to the monomeric protein, when
parasites expressing PfLCN-GFP were analyzed by western
blotting using GFP antibodies. This band is most likely derived
from dimeric PfLCN-GFP and points to a high stability of the pu-
tative PfLCN-GFP dimer, as it was not destroyed by the reducing
conditions of the SDS-PAGE. In addition, it may indicate that
PfLCN can also dimerize in vivo. In this respect, it is interesting
to note that reducing SDS-PAGE-resistant dimers have already
been observed for other lipocalins (Bhatia et al., 2012; van
Veen et al., 2006; Kielkopf et al., 2018).
PfLCN localizes to the main membrane-bound vacuolar com-
partments of the parasite, the PV and the FV. Both compart-
ments are highly sophisticated and have specialized roles that
are essential for blood-stage parasite growth. The PV is a bub-
ble-like compartment that is initiated during the process of inva-
sion through the invagination of the erythrocyte membrane. It is
bounded by the PVM, which constitutes the parasite-host cell
interface and undergoes massive remodeling after erythrocyte
infection is established. The PVM plays a central role in nutrient
acquisition, host cell remodeling, waste disposal, environmental
sensing, and protection from innate defense mechanisms (re-
viewed in Spielmann et al., 2012). Likewise, the FV is a unique
compartment that is optimized for hemoglobin metabolism. It
is the site of acidification, hemoglobin proteolysis, peptide trans-
port, heme polymerization, and detoxification of oxygen radicals
(reviewed in Wunderlich et al., 2012). In contrast to other organ-
elles (e.g., mitochondrion, apicoplast), the FV, like the PV, does
not persist throughout the whole asexual intraerythrocytic life cy-
cle. It is formed de novo and is discarded at the end of each
cycle.
Although we currently cannot completely exclude the possibil-
ity that GFP fusion of PfLCN affects its localization, the PV and
FV localization of PfLCN are in agreement with a recent study,
in which the PfLCN ortholog in the rodent malaria model
P. berghei (termed PV5) was identified as an essential PV protein
(Matz andMatuschewski, 2018). In addition, the FV localization is
further supported by mass spectrometric analysis, which(F) Growth analysis of LCN-Kd parasites over one parasite cycle grown in presenc
the ring stage or which were left untreated. In (C)–(F), relative parasitemia values
dividing the parasitemia of glucosamine/DSM1/Rapalog-treated cultures by th
absence of Trolox/E64. For statistical analysis of these experiments, a ratio-pa
indicated (**p < 0.01; ***p < 0.001; ****p < 0.0001; n.s., not significant).
(G) Live-cell image of an LCN-Kd parasite incubated with the ROS-sensitive dye
(H and I) Oxidative stress levels in LCN-Kd and LCN-Con trophozoite stage para
CellROX Orange, which shows enhanced red fluorescence upon higher levels of R
Shown are pooled data from three independent experiments in which a total of
highlighted in red. In each experiment, mean fluorescence levels and parasite size
analysis, an unpaired two-tailed Student’s t test was performed. Statistically sign
10 Cell Reports 31, 107817, June 23, 2020showed that PfLCN is part of the FV proteome (Lamarque
et al., 2008). Given these localizations and the well-established
function of lipocalins to transport small hydrophobic molecules
(Flower, 1996), PfLCNmay well have a role in transport of hydro-
phobic molecules (e.g., lipids, fatty acids) from or to the PV/FV.
Supporting this, PfLCN has a high structural similarity with the
bacterial lipocalin Blc, an E. coli outer membrane lipoprotein,
which has been shown to bind fatty acids and lyso-phospho-
lipids and is most likely involved in the transport of these in the
bacterium (Campanacci et al., 2006). However, confirmation of
a role for PfLCN in small hydrophobic molecule transport, partic-
ularly around the PV, will be addressed in future studies as our
results suggest that this protein has another important role
centered on the FV.
Our finding thatPfLCN localizes to the FV puts in context some
of our central observations of the protein knockdown: the loss of
hemozoin crystal motility within the FV and the rescue of this
motility with a radical scavenger. When we compared the struc-
ture of PfLCN to human members of the lipocalin family, it
became evident that PfLCN shows high structural similarity to
human ApoD. Interestingly, the tetramerization of ApoD under
physiological condition has recently been described (Kielkopf
et al., 2018). Human ApoD is capable of binding to a range of
small hydrophobic ligands such as progesterone and arachi-
donic acid and exerts an antioxidant function, which is partially
due to the reduction of peroxidized lipids (Bhatia et al., 2012).
This antioxidative function is conserved in ApoD homologs in
mice, in flies, and in the plant Arabidopsis thaliana (Ganfornina
et al., 2008; Sanchez et al., 2006; Walker et al., 2006; Charron
et al., 2008). Supporting a similar antioxidative function of PfLCN
at the FV, the PfLCN knockdown-induced proliferation pheno-
type could be partially chemically complemented with the radical
scavenger Trolox and by temporal inhibition of hemoglobin
digestion using the cysteine protease inhibitor E64. ROS levels
in PfLCN knockdown parasites were, however, slightly lower in
comparison to control parasites. This might be related to the
observation that PfLCN knockdown arrests the motion of hemo-
zoin crystals that, under normal circumstances, move dynami-
cally within the FV of individual parasites. This in turn might be
a sign of disordered FV physiology, likely associated with
reduced hemoglobin digestion and lower amounts of ROS being
produced. In addition to this, ROS levels might be influenced by
a PfLCN-knockdown-associated effect on parasite growth dur-
ing trophozoite development, as parasite sizes that were
measured in parallel to ROS determination, were also slightly
reduced in PfLCN-knockdown parasites.e or absence of 2.5 mM glucosamine to which 1 mME64 was added for 12 h at
of five to six independent experiments are displayed, which were obtained by
e parasitemia of the corresponding untreated ones both in the presence or
ired two-tailed t test was performed. Statistically significant differences are
CellROX orange. DIC, differential interference contrast. Scale bar, 5 mm.
sites grown in presence or absence of 2.5 mM glucosamine as measured by
OS (H). Parasite sizes (area) were measured in parallel and are displayed in (I).
114–151 parasites were analyzed per cell line and condition. Mean values are
s were set to 100% in untreated LCN-Kd and LCN-Con parasites. For statistical
ificant differences are indicated (***p < 0.001; n.s., not significant).
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parasites argue against a direct function of PfLCN in scavenging
of ROS and would instead favor a function similar to human
ApoD in mitigating oxidative stress-associated cell damage. Hu-
man ApoD catalyzes the reduction of peroxidized lipids via a
highly conserved methionine residue. Specifically, it reduces
peroxidized, potentially radical-generating hydroperoxy eicosa-
tetraenoic acids to the non-reactive hydroxide forms, whereby
lipid peroxidation chain reactions are prevented (Bhatia et al.,
2012; Dassati et al., 2014). PfLCN also contains three relatively
conserved methionine residues, two of which are within its bind-
ing pocket (Figures S1 and S4). Therefore, we can speculate that
a similar mechanism as described for ApoD might also be used
by PfLCN to limit oxidative damage, particularly in the FV. This
potential membrane protective effect agrees with our observa-
tion that PfLCN not only exists as a soluble protein, but that it
also associates with and integrates into membranes. Other lipo-
calins such as human ApoD attach to the membrane by forming
a disulfide bond with a membrane-embedded protein, but also
use a hydrophobic loop at the opening of the binding pocket to
anchor themselves into a membrane (Eichinger et al., 2007; Her-
nández-Gras and Boronat, 2015). PfLCN also contains a highly
hydrophobic loop (residues 76–79 between b4 and b5) that could
be used in the same way. This loop contains two residues of the
aromatic amino acid phenylalanine, which is often a residue
found inserted intomembranes (Wang et al., 2009). The apparent
ability of PfLCN to protect against oxidative damage might
explain why PfLCN knockdown parasites show an aberrant
late stage development, when massive amounts of new mem-
brane material has to be synthesized and protected from oxida-
tive damage that is the result of Hb digestion in the FV. How this
protectionmay occur on amolecular level and how it is related to
the localization of the protein require further investigation.
Although we have shown in our experiments using the radical
scavenger Trolox that one important function of PfLCN is likely
its protection against oxidative stress-induced cell damage, we
only observed a 50% rescue of the PfLCN deletion phenotype
upon Trolox treatment. This might on the one hand be due to
the fact that not all ROS are scavenged by Trolox at the same ef-
ficiency (Sueishi et al., 2014). On the other hand, it might well be
possible that PfLCN has other independent functions from its
antioxidative effects, such as fatty acid or lipid transport, which
contribute to the formation of abnormal schizonts observed in
this study.
Lipocalins have been hypothesized to share an early evolu-
tionary origin in the prokaryotic world, followed by an evolu-
tionary history that has been shaped by gene duplication, gene
loss, and extreme amino acid divergence in particular lineages
(Ganfornina et al., 2000). Since only a few lipocalin genes have
been identified in unicellular eukaryotes and such lipocalins do
not align well with the ones found in higher eukaryotes, previous
studies provided only limited information on putative evolu-
tionary trajectories. Likewise, our attempts to reconstruct gene
phylogenies from highly divergent primary sequences did not
provide useful evolutionary insights. We therefore aimed to
assess the representation of lipocalins across the tree of life
from available whole-genome datasets, focusing on extant alve-
olate taxa. Interestingly, when applying the same search strategyused to identify PfLCN in order to identify putative lipocalins in
other alveolate species, we found that many parasitic species
either lost or encode only one to few putative lipocalin genes,
while in most of their free-living photosynthetic relatives a higher
number of putative lipocalin genes can be found, taking different
genome sizes into account. Although we cannot rule out intra-
species duplications, this finding is in agreement with the para-
digm that the transition from free-living to parasitic lifestyle is
predominantly characterized by gene loss that has very likely
also affected the lipocalin family. Whether or not the lipocalins
of other Apicomplexans also play a role in reducing oxidative
damage, potentially as a result of host-immune responses (Sorci
and Faivre, 2009), remains to be determined.
In conclusion, using targeted sequence analysis and by solv-
ing its structure using X-ray crystallography, we were able to
describe a lipocalin in the malaria parasite. We show that PfLCN
is a protein with an important role for intraerythrocytic develop-
ment of P. falciparum and localizes to the PV and FV. We
functionally link PfLCN to oxidative damage control and provide
evidence that the antioxidative function of lipocalins not only oc-
curs in mammals, insects, and plants but also in a unicellular
eukaryote.STAR+METHODS
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Antibodies
Monoclonal mouse anti-GFP Sigma Cat. No. 11814460001; RRID:AB_390913
Rabbit-anti-aldolase Mesén-Ramı́rez et al., 2016 N/A
Mouse-anti-SBP1-N Mesén-Ramı́rez et al., 2016 N/A
Rabbit-anti-spectrin Sigma Cat. No. S1515; RRID:AB_261445
IRDye 800CW Goat anti-Mouse IgG
Secondary Antibody
LICOR Cat. No. 926-32210; RRID:AB_621842
IRDye 680RD Goat anti-Mouse IgG
Secondary Antibody
LICOR Cat. No. 926-68070; RRID:AB_10956588
IRDye 800CW Goat anti-Rabbit IgG
Secondary Antibody
LICOR Cat. No. 926-32211; RRID:AB_621843
IRDye 680RD Goat anti-Rabbit IgG
Secondary Antibody
LICOR Cat. No. 926-68071; RRID:AB_10956166
Bacterial and Virus Strains
Escherichia coli Rosetta-gami 2 (DE3) Merck Cat. No. 71351-3
Chemicals, Peptides, and Recombinant Proteins
WR99210 Jacobus Pharmaceuticals N/A
DSM1 (MRA-1161) BEI resources Cat. No. MRA 1161
Blasticidin S HCL Invitrogen Cat. No. R210-01
G418 Sigma Cat. No. A1720
DAPI (4’,6’-diamidine-20-phenylindole
dihydrochloride)
Roche Cat. No. 10236276001
D-(+)-Glucosamine hydrochloride Sigma Cat. No. G1514
Dihydroethidium Cayman Cat. No. 12013
SYBR Green Invitrogen Cat. No. S7563
Compound 2 Mike Blackman, The Francis Crick
Institute, UK
N/A
Concanavalin A Sigma Cat. No. C0412
Trolox ((±)-6-Hydroxy-2,5,7,8-
tetramethylchromane-2-carboxylic acid)
Sigma Cat. No. 238813
Diamide Sigma Cat. No. D3648
Rapalog (A/C Heterodimerizer AP21967) Clontech Cat. No. 635055
E64 protease inhibitor Biomol Cat. No. 51363.5
CellROX Orange Thermo Fisher Scientific Cat. No. C10443
Recombinant PfLCN (residues 22-217) This study N/A
Deposited Data
X-ray crystallography data of recombinant
PfLCN
This study PDB: 6TLB
SAXS data of recombinant PfLCN in
solution
This study SASBDB: SASDH92
Experimental Models: Cell Lines
Plasmodium falciparum 3D7 Walliker et al., 1987 N/A
0+ red blood cells (transfusion blood) University Medical Center Hamburg-
Eppendorf (UKE), Germany
N/A
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Experimental Models: Organisms/Strains
Plasmodium falciparum 3D7 knock in cell
line: LCN-Kd (C-terminal GFP tagging of
PfLCN with active GlmS ribozyme in the 30
UTR)
This study N/A
Plasmodium falciparum 3D7 knock in cell
line: LCN-Kd+P40PX-mCherry (C-terminal
GFP tagging of PfLCN with active GlmS
ribozyme in the 30 UTR, episomal
expression of P40PX-mCherry under nmd3
promoter)
This study N/A
Plasmodium falciparum 3D7 knock in cell
line: LCN-Comp (C-terminal GFP tagging of
PfLCN with active GlmS ribozyme in the 30
UTR, episomal expression of PfLCN-
mCherry under nmd3 promoter)
This study N/A
Plasmodium falciparum 3D7 knock in cell
line: LCN-Con (C-terminal GFP tagging of
PfLCNwith inactive GlmS ribozyme in the 30
UTR, M9 mutant)
This study N/A
Plasmodium falciparum 3D7 knock in cell
line: GFP-2 3 FKBP-Rab5a, episomal
expression of nuclear mislocalizer 1xNLS-
FRB-mCherry (knocksideways of Rab5a)
Birnbaum et al., 2017 N/A
Oligonucleotides
See Table S1 This study N/A
Recombinant DNA
pCoofy1 vector Scholz et al., 2013 Addgene plasmid 43974
pCoofy1-HIS-PfLCN This study N/A
pSLI-TGD-GFP Birnbaum et al., 2017 N/A
pSLI-PfLCN-TGD This study N/A
pSLI-PfLCN-GFP-GlmS-WT This study N/A
pSLI-PfLCN-GFP-GlmS-M9 This study N/A
pP40PX-mCherry Jonscher et al., 2019 N/A
pNMD3:PfLCN-mCherry-DHODH This study N/A
Software and Algorithms
ImageJ Schneider et al., 2012 https://imagej.nih.gov/ij/
Graphpad PRISM 6 Graphpad software N/A
Parasitemia software Grégory Burri http://www.gburri.org/parasitemia/
LICOR Image Studio 5.2 LICOR N/A
PlasmoDB Aurrecoechea et al., 2009 https://plasmodb.org/plasmo/
SUPERFAMILY 2.0 Pandurangan et al., 2019 http://supfam.org
InterPro Mitchell et al., 2019 https://www.ebi.ac.uk/interpro/
NCBI database Agarwala et al., 2018 https://www.ncbi.nlm.nih.gov/
Geneious v10.2.3 Kearse et al., 2012 https://www.geneious.com/
MUSCLE Edgar, 2004 http://www.drive5.com/muscle
msa v1.16.0 Bodenhofer et al., 2015 https://bioconductor.org/packages/msa
rotl v3.0.10 Michonneau et al., 2016 https://github.com/ropensci/rotl
Open Tree of Life v11.4 Hinchliff et al., 2015 https://opentreeoflife.github.io/
ggtree v1.16.6 Yu et al., 2018 https://bioconductor.org/packages/ggtree
XDS Kabsch, 2010 http://xds.mpimf-heidelberg.mpg.de/
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AIMLESS Evans and Murshudov, 2013 http://www.ccp4.ac.uk/html/aimless.html
Phaser McCoy et al., 2007 https://www.phaser.cimr.cam.ac.uk/index.
php/Phaser_Crystallographic_Software
MRage Bunkóczi et al., 2013 https://www.phenix-online.org/
documentation/reference/MRage.html
Buccaneer Cowtan, 2006 http://www.ysbl.york.ac.uk/cowtan/
ccp4wiki/wiki29.html
Coot Emsley et al., 2010 https://strucbio.biologie.uni-konstanz.de/
ccp4wiki/index.php/Coot
REFMAC5 Murshudov et al., 2011 http://www.ccp4.ac.uk/html/refmac5/
Molprobity Williams et al., 2018 http://molprobity.biochem.duke.edu/
Chimera Pettersen et al., 2004 http://www.rbvi.ucsf.edu/chimera/
Gesamt Krissinel, 2012 http://www.ccp4.ac.uk/html/gesamt.html
CHROMIXS Panjkovich and Svergun, 2018 https://www.embl-hamburg.de/biosaxs/
chromixs.html
DAMMIN Svergun, 1999 https://www.embl-hamburg.de/biosaxs/
dammin.html
SASREFMX Petoukhov et al., 2012 https://www.embl-hamburg.de/biosaxs/
manuals/sasrefcvmx.html
CRYSOL Svergun et al., 1995 https://www.embl-hamburg.de/biosaxs/
crysol.html
Other
Histrap 5 ml HP GE Healthcare Cat. No. 17524801
Amicon centrifugal concentrators Merck Cat. No. UFC901008
3C protease Selfmade N/A
Swissci crystal plates Hampton research Cat. No. HR3-082
JCSG crystal screens I-IV QIAGEN Cat. No. 130724, Cat. No. 130725, Cat. No.
130726, Cat. No. 130727
Percoll GE Healthcare Cat. No. 17-0891-02





Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Tim-Wolf
Gilberger (gilberger@bnitm.de).
Materials Availability
All plasmids and cell lines generated in this study are available from the Lead Contact with a completed Materials Transfer
Agreement.
Data and Code Availability
All data generated or analyzed during this study are included in this published article and its supplemental material files. The structural
data have been deposited in the PDB under the accession code 6TLB. All SAXS data is available in the Small Angle Scattering Bio-
logical Data Bank, SASBDB, under the accession code SASDH92.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
E.coli Expression Bacteria
PfLCN was expressed in E. coli Rosetta-gami 2 (DE3) (Merck) in Terrific Broth medium using standard protocols. For more informa-
tion on recombinant expression, see Method Details.Cell Reports 31, 107817, June 23, 2020 e3
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Blood stages of P. falciparum parasites (strain 3D7) (Walliker et al., 1987) were cultured in human O+ erythrocytes from transfusion
blood concentrate. Cultures were maintained at 37C in an atmosphere of 1% O2, 5% CO2, and 94% N2 and cultured using RPMI
complete medium containing 0.5% Albumax according to standard procedures (Trager and Jensen, 1976).
Human Erythrocytes
0+ erythrocytes were obtained from commercially purchased blood concentrates (transfusion blood, Universitätsklinikum Hamburg-
Eppendorf; Approval number 10569a/96-1). One ml of transfusion blood concentrate contained 0.5-0.7 mL of human erythrocytes,
0.28-0.44 mL SAG-M (consisting of 9.0 mg glucose monohydrate, 0.17 mg adenine, 5.25 mg mannitol, 8.77 mg NaCl per ml dH2O),
0.015 - 0.05 mL of human plasma, and 0.005 - 0.01 mL stabilizing solution (consisting of 26.3 mg sodium citrate, 3.27 mg citric acid
monohydrate, 25.5 mg glucose monohydrate, 2.51 mg sodium dihydrogenphosphate dihydrate per ml dH2O). Blood concentrates
are anonymous and age or gender of the blood donors were not known.
METHOD DETAILS
Bioinformatic Analyses
Searching the PlasmoDB database for genes annotated as members of the lipocalin superfamily (SUPERFAMILY: SSF50814; (Pan-
durangan et al., 2019)) or the calycin homologous superfamily (InterPro: IPR012674; (Mitchell et al., 2019)) revealed the protein coding
gene PF3D7_0925900 as putative lipocalin. We performed batch blastp searches of PfLCN (PF3D7_0925900) against the nr and
env_nr database (Agarwala et al., 2018) using Geneious 10.2.3 (Kearse et al., 2012) using an E-value of 10e-0 (BLOSUM62 substi-
tution matrix) to identify close homologs in related apicomplexan species. A multiple sequence alignment of putative lipocalins iden-
tified in Plasmodium species was performed using MUSCLE (Edgar, 2004) implemented in the R package msa v1.16.0 (Bodenhofer
et al., 2015).
We then used the InterPro (Mitchell et al., 2019) and SUPERFAMILY 2.0 database (Pandurangan et al., 2019) to identify and count
the number of lipocalin superfamily members in selected alveolate and outgroup species to perform an evolutionary analysis. The R
package rotl v3.0.10 (Michonneau et al., 2016) was used to extract a phylogenetic tree from the Open Tree of Life v11.4 synthetic tree
(Hinchliff et al., 2015) summarizing current phylogenetic and taxonomic information. Additionally, we obtained genome size data from
the NCBI genome database (Agarwala et al., 2018) and visualized the phylogenetic tree and associated protein count and genome
size data using the R package ggtree v1.16.6 (Yu et al., 2018).
Protein Expression and Purification
The coding sequence of PfLCN (corresponding to residues 22-217 and lacking the 21 amino acid N-terminal signal sequence) was
PCR amplified from blood stage cDNA using primers recPfLCN-fw and recPfLCN-rev and cloned into the pCoofy1 vector (Scholz
et al., 2013) (Addgene plasmid number 43974) containing an N-terminal hexahistidine tag followed by a 3C PreScission protease
site (sequence: LEVLFQG) using the SLiCE cloning method (Zhang et al., 2014). The vector was transformed into Rosetta-gami 2
(DE3) (Merck) cells using standard protocols. Cells were grown to an OD600 of 1.0 in Terrific Broth media at 37
C before induction
with 0.5 mM IPTG at 20C for 18 h. Cells were pelleted by centrifugation (9373 g) and resuspended in lysis buffer (20 mM Tris pH
7.5, 100 mM NaCl, 20mM imidazole, 5% (v/v) glycerol) before lysis with the Avestin EmulsiFlex C3 french press. Unlysed cells
and precipitates were removed by centrifugation (29616 g) and the supernatant was collected and filtered. Filtered lysate was
then flowed over Ni-NTA agarose resin (GE Healthcare) at 2.5 mL min-1 before a 7-column volume wash with lysis buffer. PfLCN
was eluted using a step gradient with elution buffer (20mMTris pH 7.5, 100mMNaCl, 500mM imidazole, 5% (v/v) glycerol). Fractions
were collected and pooled and 1 mg 3C protease was added. The PfLCN and 3C protease mixture was dialysed against 20 mM Tris
pH 7.5, 100 mM NaCl, 5% (v/v) glycerol using 8 kDa MW cut-off dialysis tubing overnight at 4C. Reverse Ni-NTA was performed to
remove cleaved hexahistidine tag and 3C protease and the flowthrough was concentrated in a 10 kDa Amicon Ultra centrifugal filter
(Merck Millipore). Protein was injected onto a HiLoad 16/60 Superdex 75 prep grade size exclusion chromatography column running
dialysis buffer at 1 mL min-1. Fractions were pooled and concentrated using the same Amicon concentrator. The protein concentra-
tion was measured using OD280 on a Nanodrop using the extinction coefficient calculated from the primary sequence before flash
freezing and storage at 80C. All primer sequences are listed in Table S1.
Crystallization and Data Collection
Crystallization screenings were carried out using the sitting-drop vapor diffusion method in Swissci plates (Hampton Research) and
with aMosquito nanolitre-dispensing crystallization robot. 25mg/ml of recombinant PfLCN in precipitant to protein volume ratios 1:2,
1:1, 2:1were used for screening in QIAGEN JCSGCore I-IV screens (QIAGEN). The crystals appeared around 30 days in 0.1MTris pH
7, 0.2MMgCl2, 2.5 MNaCl, and these were cryoprotected in the same buffer plus 20%glycerol. X-ray diffraction data were collected




All work was performed using the CCP4i2 (Potterton et al., 2018) suite unless stated. The dataset was integrated using XDS (Kabsch,
2010) and scaled using AIMLESS (Evans andMurshudov, 2013). The solution of the tetrameric asymmetric unit was obtained by mo-
lecular replacement using Phaser (McCoy et al., 2007) with amodel generated andmodified by the Phenix MRage pipeline (Bunkóczi
et al., 2013) based on Blc from E. coli (PDB code 3MBT). The initial model was built by Buccaneer (Cowtan, 2006), refined in real
space with Coot (Emsley et al., 2010) and reciprocal space with REFMAC5 (Murshudov et al., 2011). Structure was validated using
Molprobity (Williams et al., 2018) and displayed using Chimera (Pettersen et al., 2004). The software Gesamt was used for assessing
structural similarities between PfLCN and human lipocalins (Krissinel, 2012).
SAXS and SEC-SAXS
Synchrotron SAXS data were measured from the PfLCN protein through a concentration series using a standard batch setup as well
as in-line size-exclusion chromatography SAXS (SEC-SAXS). All samples were reconstituted in 20mMTris pH 7.5, 100mMNaCl, 5%
v/v glycerol. The data were collected on the EMBL P12 bioSAXS beam line at PETRA III (Deutsches Elektronen-Synchrotron,
Hamburg, Germany) equipped with a 2D Pilatus 6M area detector at a sample-detector distance of 3 m and at a wavelength of
l = 0.124 nm (I(s) versus s, where s = 4psinq/l, and 2q is the scattering angle). For the batch measurements, the sample concentra-
tions were: 10, 5, 2 and 1mg/ml (20 successive 0.050 s frameswere collected for each sample at 10C, in addition to the correspond-
ingmatched solvent blank). All 2D-data were normalized to the intensity of the transmitted beam to take into account sample absorp-
tion and subsequently radially averaged to produce 1D-scattering profiles. The scattering from the the solvent-blank was subtracted
to generate the final SAXS data of the PfLCN protein mixtures. The SEC parameters were as follows: A 75 mL sample at 10mg/ml was
injected at a flow rate of 0.35 ml/min onto a GE Superdex 200 Increase 10/300 column at 20C. 56 successive 1 s frames were
collected through the major SEC-elution peak and processed using CHROMIXS (Panjkovich and Svergun, 2018) that included the
subtraction of an appropriate solvent blank measured from the protein-free column eluate. The ab initio dummy atom modeling
was performed using DAMMN (Svergun, 1999) while CRYSOL (Svergun et al., 1995) was used to assess the fit of the X-ray crystal
structure to the data. SASREFMX (Petoukhov et al., 2012) was used as a rigid-body modeling routine to generate atomistic models
from the X-ray crystal structure to represent the solution-states and volume fractions of the PfLCN oligomeric mixtures at different
sample concentrations.
Generation of Transfection Plasmids
To generate the plasmid pSLI-PfLCN-TGD, 258 bp of the N-terminal PfLCN coding sequence were amplified by PCR from genomic
DNA using primers PfLCN-TGD-fw and PfLCN-TGD-rev and cloned into pSLI-TGD-GFP (Birnbaum et al., 2017) using NotI and MluI
restriction sites.
To generate pSLI-GFP-GlmS-WT and pSLI-GFP-GlmS-M9, the glmS-WT and glmS-M9 sequences were amplified by PCR from
pARL-HA-glmS (Flammersfeld et al., 2020) using primers GlmS-WT-fw/GlmS-rev (WT) or GlmS-M9-fw/GlmS-rev (M9) and cloned via
XhoI into pSLI-TGD-GFP (Birnbaum et al., 2017). Next, 495 bp of the C-terminal PfLCN coding sequence omitting the stop codon
were amplified by PCR from genomic DNA using PfLCN-GFP-fw and PfLCN-GFP-rev and cloned via NotI and MluI into pSLI-
GFP-GlmS-WT and pSLI-GFP-GlmS-M9 to generate the final targeting constructs pSLI-PfLCN-GFP-GlmS-WT and pSLI-PfLCN-
GFP-GlmS-M9.
For generation of thePfLCN gene complementation vector pNMD3:PfLCN-mCherry-DHODH, the PfLCN coding sequencewithout
stop codon was amplified by PCR from genomic DNA using primers PfLCN-Comp-fw and PfLCN-Comp-rev and cloned via XhoI and
SpeI into the pNMD3:1xNLS-FRB-mCherry-DHODH plasmid (Birnbaum et al., 2017) replacing the 1xNLS-FRB sequence with the
PfLCN coding sequence. All primer sequences are listed in Table S1.
Transfection of P. falciparum
For transfection of constructs, 60%Percoll-enriched synchronizedmature schizonts were electroporated with 50 mg of plasmid DNA
using a Lonza Nucleofector II device (Moon et al., 2013). Selection was done either with 3 nMWR99210 (Jacobus Pharmaceuticals),
0.9 mM DSM1 (BEI Resources) or 2 mg/ml Blasticidin S (Invitrogen). For generation of stable integrant cell lines, parasites containing
the episomal plasmids selected with WR99210 were grown with 400 mg/ml G418 (Sigma) to select for integrants carrying the desired
genomic modification as described previously (Birnbaum et al., 2017).
Transgenic Parasite Lines
The two targeting constructs pSLI-PfLCN-GFP-GlmS-WT and pSLI-PfLCN-GFP-GlmS-M9were transfected as described above into
P. falciparum 3D7 parasites, which were then subjected to sequential WR99210 and G418 selection resulting in LCN-Kd (GlmS-WT)
and LCN-Con (GlmS-M9) parasites. To confirm correct integration, genomic DNA from parasites selected under G418 aswell as from
3D7/WT parasites was preparedwith theQIAampDNAMini Kit (QIAGEN) and analyzed by PCR using primers specific for the 50 and 30
integration junctions of the PfLCN locus and primers to detect the original locus. For visualization of the FV membrane, LCN-Kd
parasites were transfected with the plasmid pP40PX-mCherry (Jonscher et al., 2019) and selected with Blasticidin S. For gene
complementation of PfLCN, LCN-Kd parasites were transfected with the pNMD3:PfLCN-mCherry-DHODH plasmid and transgenic




For live-cell microscopy, LCN-Kd parasites were incubated with 1 mg/ml DAPI in culture medium for 15 min at 37C to stain nuclei.
Parasites were then washed once in PBS and imaged in PBS on a Leica D6B fluorescence microscope equipped with a Leica
DFC9000 GT camera and a Leica Plan Apochromat 100x/1.4 oil objective. Image processing was performed using ImageJ
(Schneider et al., 2012).
Solubility Assay
For determination of membrane association, trophozoite stage LCN-Kd parasites from two 10 mL dishes (4% hematocrit, 5%–10%
parasitemia) were isolated using a Percoll gradient as previously described (Heiber and Spielmann, 2014) and released from eryth-
rocytes using 0.03% saponin in 200 mL of PBS for 10 min (if not otherwise indicated, all steps were carried out on ice). After centri-
fugation at 16.000 g for 10min, the pellet was 3x washed in PBS, complete protease inhibitor (Roche) was added to the pellet and the
parasites were lysed in 200 mL of 5 mM Tris-HCl pH 8.0 and frozen at80C. After another three freeze thaw cycles in liquid nitrogen,
extraction was performed sequentially: The lysate was centrifuged at 16.000 g for 10 min. The supernatant was removed, recentri-
fuged for 5 min to remove residual insoluble material and saved as the soluble protein fraction. The pellet of the hypotonic lysis was
resuspended in 200 mL of freshly prepared 0.1 M Na2CO3 and stored on ice for 30 min to extract peripheral membrane proteins. After
centrifugation, the supernatant was saved, the pellet extracted for 30 min with 200 mL 1% Triton X-100 and centrifuged to obtain the
integral membrane protein fraction in the supernatant. The pellet was resuspended in PBS, representing the insoluble fraction.
Reducing SDS sample buffer was added to all supernatants as well as to the insoluble fraction and equal amounts of all samples
were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) and western blotting.
Immunoblotting
Protein samples were resolved by SDS-PAGE and transferred to nitrocellulosemembranes (LICOR).Membranes were blocked in 5%
milk in TBS-T followed by incubation in the following primary antibodies that were diluted in TBS-T containing 5%milk: mouse-anti-
GFP (Sigma, 1:1000), rabbit-anti-aldolase (Mesén-Ramı́rez et al., 2016) (1:2000), mouse-anti-SBP1-N (Mesén-Ramı́rez et al., 2016)
(1:2000) and rabbit-anti-spectrin (Sigma, 1:2000). After 3x washing in TBST-T, membranes were incubated in similarly diluted sec-
ondary antibodies: goat-anti-mouse-800CW (LICOR, 1:10.000), goat-anti-rabbit-680RD (LICOR, 1:10.000), goat-anti-mouse-680RD
(LICOR, 1:10.000) and goat-anti-rabbit-800CW (LICOR, 1:10.000). Subsequently, membranes were washed another three times with
TBST-T and scanned on a LICOR Odyssey FC imager.
PfLCN Knockdown and Phenotypic Analysis
To induce knockdown of PfLCN, 2.5 mM glucosamine (Sigma) was added to highly synchronous early ringstage LCN-Kd parasites.
As a control, the same amount of glucosamine was also added to LCN-Con parasites. For all analyses, medium was changed daily
and fresh glucosamine and/or compounds were added every day.
For quantification of knockdown efficiency, untreated and glucosamine-treated LCN-Kd and LCN-Con trophozoite stage parasites
from one 10mL dish (4% hematocrit, 5%–10%parasitemia) were isolated using a Percoll gradient 24 h after glucosamine addition as
previously described (Heiber and Spielmann, 2014), directly lysed in reducing SDS-sample buffer and analyzed by SDS-PAGE and
western blotting as explained above. Quantifications of PfLCN-GFP and aldolase levels were performed using the LICOR Image Stu-
dio 5.2 software.
For growth analyses over four parasite cycles, highly synchronous early ring stage parasites were diluted to approximately 0.1%
parasitemia in 2 mL dishes (5% hematocrit) and analyzed by FACS as trophozoite stage parasites 1, 3, 5, and 7 days post-invasion.
After analysis on day 5, parasites were split 1:10 to prevent overgrowth of cultures. For growth analyses over one parasite cycle,
highly synchronous ring stage cultures were diluted to 1% parasitemia in 2 mL dishes and were analyzed by flow cytometry in the
subsequent cycle as trophozoite stage parasites.
Flow cytometry-based analysis of growth was performed basically as described previously (Malleret et al., 2011). In brief, 20 mL
resuspended parasite culture was incubated with dihydroethidium (5 mg/ml) and SYBR Green (0.25 x dilution) in a final volume of
100 mL medium for 20 min at RT protected from light. Samples were analyzed on an ACEA NovoCyte flow cytometer. Erythrocytes
were gated based on their forward and side scatter parameters. For every sample, 100,000 events were recorded and parasitemia
was determined based on SYBR Green fluorescence.
For stage quantifications and analysis of schizont morphology, schizont stage parasites were isolated by 60% Percoll purification
and incubated with uninfected erythrocytes for three hto allow rupture and invasion. Parasites were then treated with 5% sorbitol to
remove any unruptured schizonts, leading to a 3h synchronous ring stage culture. Next, parasite cultures were diluted to approxi-
mately 1% parasitemia in 2 mL dishes (5% hematocrit) and Giemsa-stained blood smears were prepared at 24, 40 and 48 hpi.
For stage quantifications, at least 20 fields of view were recorded using a 63x objective per treatment and time point. Erythrocyte
numbers were then determined using the automated Parasitemia software (http://www.gburri.org/parasitemia/) and the numbers
of rings, trophozoites and schizonts weremanually counted on these images. For analysis of schizontmorphology, 1 mMof the egress
inhibitor compound 2 was added to schizont stage parasites at 40 hpi. After 8 h, Giemsa-stained blood smears were prepared and
schizont morphology was investigated by light-microscopy.e6 Cell Reports 31, 107817, June 23, 2020
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Schizont stage parasites were isolated by 60% Percoll purification and incubated with uninfected erythrocytes for three h to allow
rupture and invasion. Parasites were then treated with 5% sorbitol to remove any unruptured schizonts. Parasites were subsequently
left untreated or treatedwith 2.5mMglucosamine in presence or absence of 100 mMTrolox for 27 h under standard culture conditions
until transfer onto imaging dishes. Treatments with 10 mM diamide in presence or absence of 100 mM Trolox were initiated 24 h after
sorbitol treatment and lasted for 3 h before parasites were also transferred onto imaging dishes. After the respective treatments, par-
asites were washed with PBS and trophozoites were isolated by using a Percoll gradient (Heiber and Spielmann, 2014). Enriched
trophozoites were then resuspended in 500 ml of complete medium (if necessary with glucosamine, Trolox or diamide) and parasites
were allowed to settle on 4 chamber glass bottom dishes (Cellvis) for 1 h under standard culture conditions. Imaging dishes were
concanavalin A coated beforehand by incubation with 0.5mg/ml concanavalin A (Sigma) dissolved in H2O for 15min at 37
C followed
by washing with PBS. Parasites were then imaged using an inverted Leica DFC9000 GT camera and a Leica Plan Apochromat 100x/
1.4 oil objective andwere kept at 37C for the duration of the experiment. To generate the videos used for assessing hemozoin crystal
motility, one image per sec was taken over an imaging period of one min. For quantifications, video files were imported into ImageJ,
where the total number of parasites and the number of parasites with motile hemozoin crystals were quantified.
Measurement of Oxidative Stress
For measurement of oxidative stress levels, LCN-Kd and LCN-Con ring stage parasites were treated with 2.5 mM glucosamine or
were left untreated. At around 30 hpi, trophozoite stage parasites were stained with 5 mMCellROX Orange (Thermo Fisher Scientific)
in culture medium for 30 min at 37C. After three washes with PBS, they were directly imaged on a Leica D6B fluorescence micro-
scope as described above. Mean fluorescence intensities and size (area) of individual parasites were determined using the ROI man-
ager of ImageJ (Schneider et al., 2012).
QUANTIFICATION AND STATISTICAL ANALYSIS
For statistical analysis of differences between two groups, an unpaired two-tailed Student’s t test or a ratio-paired two-tailed t test
was used. For statistical analysis of differences betweenmore than two groups, a one-way analysis of variance (ANOVA), followed by
a Holm-Sidak multiple-comparison test was performed. All statistical tests were done in GraphPad Prism 6. p values of <0.05 were
considered significant. Statistical details (n numbers, tests used, definition of the error bars) are described in the figure legends.Cell Reports 31, 107817, June 23, 2020 e7
